WH Bakker
- Epidemiology top 5%
- Oncology top 10%
- Neurology top 5%
- Radiology, Nuclear Medicine and Imaging top 5%
- Endocrinology, Diabetes and Metabolism
- Co-authors
- E. P. KrenningT.J. VisserDik J. KwekkeboomMarion de JongCh. BrunsJean Claude ReubiP.P.M. KooijHelmut R. Mäcke
- Topics
- Neuroendocrine Tumor Research Advances (13 papers)Radiopharmaceutical Chemistry and Applications (9 papers)Lung Cancer Research Studies (8 papers)
- Cited by
- NeurologyEpidemiologyOncology
- Journals
- European Journal of CancerEuropean Journal of Nuclear Medicine and Molecular ImagingLung Cancer
- Partner nations
- NetherlandsUnited StatesGermany
In The Last Decade
WH Bakker
16 papers receiving 759 citations
Peers
Comparison fields: 5 of 58
- Epidemiology 583
- Oncology 455
- Neurology 371
- Radiology, Nuclear Medicine and Imaging 327
- Endocrinology, Diabetes and Metabolism 83
Countries citing papers authored by WH Bakker
This map shows the geographic impact of WH Bakker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by WH Bakker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites WH Bakker more than expected).
Fields of papers citing papers by WH Bakker
This network shows the impact of papers produced by WH Bakker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by WH Bakker. The network helps show where WH Bakker may publish in the future.
Co-authorship network of co-authors of WH Bakker
This figure shows the co-authorship network connecting the top 25 collaborators of WH Bakker. A scholar is included among the top collaborators of WH Bakker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with WH Bakker. WH Bakker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | Phase 1 study of peptide receptor radionuclide therapy (PRRT) with [Y-90-DOTA,Tyr(3)]octreotide in patients with somatostatin receptor positive tumors | 7 |
| 2 | Peptide receptor radionuclide therapy (PRRT) with Y-90-DOTA(0),Tyr(3)-octreotide (Y-Oc) and In-111-DTPA(0)-octreotide (In-Oc): Comparison of tumor response and toxicity. | 4 |
| 3 | Phase I study of therapy with Y-90-SMT487 (octreother) in patients with somatostatin receptor (SS-R) positive tumors. | 16 |
| 4 | Safety and efficacy of [Y-90-DOTA,Tyr(3)]-octreotide (Y-90-SMT487; OctreoTher) peptide receptor radionuclide therapy (PRRT). Preliminary results of a phase-1 study | 10 |
| 5 | Tumor dosimetry based on PET Y-86-DOTA-Tyr3-octreotide (SMT487) and CT-scan predicts tumor response to Y-90-SMT487 (OctreoTher (TM)) therapy. | 7 |
| 6 | Targeted radiotherapy with Y-90-DOTA-TYR3-octreotide (Y-90-SMT487; OctreoTher (TM)): A phase I study. | 7 |
| 7 | 8 | |
| 8 | 7 | |
| 9 | Scintigraphy and radionuclide therapy with [indium-111-labelled-diethyl triamine penta-acetic acid-D-Phe1]-octreotide. | 93 |
| 10 | Comparison of 111In-DOTA-Tyr3-octreotide and 111In-DTPA-octreotide in the same patients: biodistribution, kinetics, organ and tumor uptake. | 90 |
| 11 | Comparison of (111)In-labeled somatostatin analogues for tumor scintigraphy and radionuclide therapy. | 181 |
| 12 | 1 | |
| 13 | Somatostatin receptor scintigraphy with indium-111-DTPA-D-Phe-1-octreotide in man: metabolism, dosimetry and comparison with iodine-123-Tyr-3-octreotide. | 337 |
| 14 | 11 | |
| 15 | 1 | |
| 16 | 10 |
About WH Bakker
WH Bakker is a scholar working on Radiology, Nuclear Medicine and Imaging, Epidemiology and Oncology, having authored 16 papers that have together received 790 indexed citations. Recurring topics across this work include Neuroendocrine Tumor Research Advances (13 papers), Radiopharmaceutical Chemistry and Applications (9 papers) and Lung Cancer Research Studies (8 papers). The work is most often cited by research in Neurology (371 citations), Epidemiology (583 citations) and Oncology (455 citations). WH Bakker has collaborated with scholars based in Netherlands, United States and Germany. Frequent co-authors include E. P. Krenning, T.J. Visser, Dik J. Kwekkeboom, Marion de Jong, Ch. Bruns, Jean Claude Reubi, P.P.M. Kooij, Helmut R. Mäcke, A. Srinivasan and Roelf Valkema. Their work appears in journals such as European Journal of Cancer, European Journal of Nuclear Medicine and Molecular Imaging and Lung Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.